Jordan Feld
Overview
Explore the profile of Jordan Feld including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
45
Citations
1136
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Imsirovic H, Macphail G, Conway B, Fraser C, Borgia S, Smyth D, et al.
J Viral Hepat
. 2024 Aug;
31(11):775-779.
PMID: 39135466
The prevalence of mixed hepatitis C virus (HCV) genotype infection in a representative Canadian HCV cohort is reported and virological response with direct acting antiviral (DAA) treatment was evaluated. 3272...
2.
Wong R, Hirode G, Feld J, Wong S, Brosgart C, Glenn J, et al.
J Viral Hepat
. 2024 Apr;
31(6):324-341.
PMID: 38619214
Foreign-born (FB) persons represent a large proportion of adults with chronic hepatitis B (CHB) in Canada due to higher prevalence rates in countries of birth for FB persons. Suboptimal awareness...
3.
Wong R, Brosgart C, Wong S, Feld J, Glenn J, Hamid S, et al.
Liver Int
. 2024 Apr;
44(7):1715-1734.
PMID: 38563728
Background And Aims: Suboptimal awareness and low rates of hepatitis delta virus (HDV) testing contribute to underdiagnosis and gaps in accurate estimates of U.S. HDV prevalence. We aim to provide...
4.
Popovic N, Williams A, Perinet S, Campeau L, Yang Q, Zhang F, et al.
Can Commun Dis Rep
. 2024 Jan;
48(11-12):540-549.
PMID: 38222827
Background: Estimates of the number of hepatitis C virus (HCV) infections are important for monitoring efforts aimed at preventing disease transmission, especially following the introduction of a highly effective treatment....
5.
Andrews T, Nakib D, Perciani C, Ma X, Liu L, Winter E, et al.
J Hepatol
. 2024 Jan;
80(5):730-743.
PMID: 38199298
Background & Aims: Primary sclerosing cholangitis (PSC) is an immune-mediated cholestatic liver disease for which there is an unmet need to understand the cellular composition of the affected liver and...
6.
Briere R, Emond M, Benhamed A, Blanchard P, Golbon B, Shellenberger J, et al.
Can J Surg
. 2024 Jan;
66(6 Suppl 1):S54-S136.
PMID: 38173057
No abstract available.
7.
Chu C, Gomes T, Antoniou T, Wong W, Janjua N, Guertin J, et al.
PLoS One
. 2023 Aug;
18(8):e0284914.
PMID: 37552677
Background: Hepatitis C virus (HCV) has high global prevalence and can lead to liver complications and death. Access to direct-acting antivirals (DAAs) in Canada increased following several policy changes, however...
8.
Koopsen J, Matthews G, Rockstroh J, Applegate T, Bhagani S, Rauch A, et al.
Lancet Microbe
. 2023 Jun;
4(8):e622-e631.
PMID: 37336226
Background: Microelimination of the hepatitis C virus (HCV) among men who have sex with men (MSM) could be complicated by continuous external introductions and the emergence of phylogenetic clusters harbouring...
9.
Genshaft A, Subudhi S, Keo A, Vasquez J, Conceicao-Neto N, Mahamed D, et al.
Hepatology
. 2023 May;
78(5):1525-1541.
PMID: 37158243
Background And Aims: HBV infection is restricted to the liver, where it drives exhaustion of virus-specific T and B cells and pathogenesis through dysregulation of intrahepatic immunity. Our understanding of...
10.